Predictive biomarkers in radioresistant rectal cancer: A systematic review
-
Published:2023-06
Issue:
Volume:186
Page:103991
-
ISSN:1040-8428
-
Container-title:Critical Reviews in Oncology/Hematology
-
language:en
-
Short-container-title:Critical Reviews in Oncology/Hematology
Author:
Slipsager AnnaORCID,
Henrichsen Sofie N.,
Falkmer Ursula G.,
Dybkær Karen,
Belting Mattias,
Poulsen Laurids Ø.
Subject
Oncology,Hematology
Reference56 articles.
1. The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study;Abdul-Jalil;Ann. Surg. Oncol.,2014
2. A. Alkan, T. Hofving, E. Angenete, U. Yrlid, Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients, pp. 1–17, 2021.
3. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2);Allemani;Lancet,2015
4. Late adverse effects of radiation therapy for rectal cancer - a systematic overview;Birgisson;Acta Oncol.,2007
5. Reg4 interacts with CD44 to regulate proliferation and stemness of colorectal and pancreatic cancer cells;Bishnupuri;Mol. Cancer Res.,2022